This presentation contains results from the MAARC’s third AmeriSpeak Brief Stigma Survey (JCOIN 026) done in June 2020. NORC conducted a third cross-sectional national survey of the U.S. adult population, using AmeriSpeak’s® web, probability-based panel. The third of the AmeriSpeak Omnibus Surveys continues NORC’s work measuring stigma and opioid use disorder (OUD) but adds questions related to community perceptions of opioid use disorder treatment and recovery. There were also a few COVID related questions that were repeated from Survey 2 that were covered in this third survey. The focus on the general public’s views on treatment and recovery came from input from MAARC reviewers and the JCOIN Survey Advisory Workgroup members. Survey 3 improves our understanding of patterns in stigma across multiple dimensions of OUD and informs future efforts including qualitative data collection and the custom AmeriSpeak survey scheduled in year two.
This study was developed by Bruce Taylor, Ph.D., Phoebe Lamuda, Elizabeth Flanagan, and Beth Watts, Ph.D. at the NORC at the University of Chicago as part of the Methodology and Advanced Analytics Resource Center (MAARC).
The Justice Community Opioid Innovation Network (JCOIN) is part of the NIH HEAL (Helping to End Addiction Long-termSM) Initiative, which supports a wide range of programs to develop new or improved prevention and treatment strategies for opioid addiction.
This research was supported by the National Institutes of Health (NIH) through the NIH HEAL Initiative under award number U2CDA050098. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH, the NIH HEAL Initiative, or the participating sites.
NORC (June 2020). The general public’s views towards recovery and treatment from opioid use disorder and JCOIN core items: An AmeriSpeak JCOIN Omnibus General Population Survey 3. Chicago, IL: NORC.